Chemoinformaics analysis of 8-Acetoxy-5-hydroxyumbelliprenin
| Molecular Weight | 440.536 | nRot | 10 |
| Heavy Atom Molecular Weight | 408.28 | nRig | 16 |
| Exact Molecular Weight | 440.22 | nRing | 2 |
| Solubility: LogS | -4.915 | nHRing | 1 |
| Solubility: LogP | 3.94 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 11 |
| nHA | 6 | APOL | 69.5694 |
| nHD | 1 | BPOL | 39.0466 |
| QED | 0.314 |
| Synth | 3.906 |
| Natural Product Likeliness | 1.934 |
| NR-PPAR-gamma | 0.4 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.059 |
| Pgp-sub | 0.636 |
| HIA | 0.871 |
| CACO-2 | -4.762 |
| MDCK | 0.0000221 |
| BBB | 0.112 |
| PPB | 0.953744 |
| VDSS | 1.185 |
| FU | 0.0661661 |
| CYP1A2-inh | 0.703 |
| CYP1A2-sub | 0.385 |
| CYP2c19-inh | 0.902 |
| CYP2c19-sub | 0.206 |
| CYP2c9-inh | 0.823 |
| CYP2c9-sub | 0.899 |
| CYP2d6-inh | 0.688 |
| CYP2d6-sub | 0.76 |
| CYP3a4-inh | 0.672 |
| CYP3a4-sub | 0.354 |
| CL | 10.425 |
| T12 | 0.417 |
| hERG | 0.005 |
| Ames | 0.072 |
| ROA | 0.029 |
| SkinSen | 0.19 |
| Carcinogencity | 0.068 |
| EI | 0.01 |
| Respiratory | 0.498 |
| NR-Aromatase | 0.714 |
| Antiviral | Yes |
| Prediction | 0.728733 |